An all-oral option for advanced HR+, HER2– breast cancer?December 17, 2020Breast CancerMetastatic Breast Cancer
Vaccine-preventable infection risk high for pediatric hematopoietic cell transplantation recipientsDecember 17, 2020Pediatrics
COVID-19 vaccines: Safe for immunocompromised patients?December 17, 2020COVID-19 UpdatesGastroenterologyGastrointestinal Cancer
On the horizon: Asciminib, a new drug for treating r/r CMLDecember 16, 2020Lymphoma & Plasma Cell Disorders
Pembro benefits in mTNBC regardless of chemo typeDecember 16, 2020Breast CancerMetastatic Breast Cancer
Four-item prognostic index predicts survival in adult Burkitt lymphomaDecember 16, 2020Lymphoma & Plasma Cell Disorders
Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapyDecember 16, 2020Leukemia, Myelodysplasia, Transplantation
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myelomaDecember 15, 2020Lymphoma & Plasma Cell Disorders
